The Bowral Classic is excited to announce The Kids’ Cancer Project as a charity partner in 2016.
The leading not for profit received overwhelming support when the cycling community was asked which charities the Challenge should support. The Kids’ Cancer Project is an independent charity dedicated to helping kids with cancer through research.
It was wonderful to see the ‘buy-in’ from our cycling community for this worthy charity. With over nine hundred and fifty children diagnosed annually in Australia and tragically killing more children than any other disease – it’s vital we do our part to raise awareness and funds for research.
“Childhood cancer is different to adult cancer which can be caused through age and lifestyle factors. With no known causes, there is no way to prevent childhood cancer,” explained Owen Finegan Chief Executive of The Kids’ Cancer Project. Finegan was an integral part of the Australian Rugby Union team the Wallabies for a decade following his first appearance in 1996. He won 56 international matches with the Wallabies and played 90 ‘Super 12’ matches for the ACT Brumbies.
“Thanks to community support we are able to fund the best researchers across Australia working in childhood cancer. Our research priorities allow us to participate in areas that have the greatest impact on survivorship while minimising the effects of toxic treatments,” said Owen.
“There are rides for all levels of cycling ability by taking on a physical challenge you are acknowledging the challenges facing these kids and their families – I encourage everyone to join the Bowral Classic and ride for us!” You can do so as an individual or team. Head to the Kids’ Cancer Project charity page on the Bowral Classic Website to get started.
Over $27 million has been invested in childhood cancer research by the charity, with three clinical trials currently providing better treatments to children diagnosed with cancer.
The DFMO clinical trial, developed from research conducted at the Children’s Cancer Institute, involves sixteen hospitals in Australia and The United States. The Phase I clinical trial supported by The Kids’ Cancer Project involves children with relapsed high risk neuroblastoma who have a 1 in 5 chance of surviving their relapse.